Corteva's fourth-quarter 2023 results showed a decrease in net sales and a GAAP loss, but operating EBITDA improved. The decline was attributed to volume decreases, especially in Latin America, while price increases partially offset the negative impact. The company provided 2024 guidance, expecting net sales and operating EBITDA growth.
Net sales decreased by 3% compared to the same period last year, with organic sales declining by 8%.
GAAP income from continuing operations after income taxes was a loss of $231 million, compared to a loss of $41 million in the prior year.
Operating EBITDA increased by 4% compared to the prior year, reaching $386 million.
Seed net sales decreased slightly, driven by a volume decline, while Crop Protection net sales also declined due to lower volume and price.
Corteva provided full-year 2024 guidance and expects net sales in the range of $17.4 billion to $17.7 billion, Operating EBITDA to be in the range of $3.5 billion to $3.7 billion, and Operating EPS to be in the range of $2.70 to $2.90 per share.
Visualization of income flow from segment revenue to net income